Clinical Review: Is the Perioperative Use of {beta}-Blockers Still Recommended? A Critical Review of Recent Controversies
Domanski and Schwarz
J CARDIOVASC PHARMACOL THER 2009;14:258-268.
ABSTRACT
Parasympathetic effects on cardiac electrophysiology during exercise and recovery in patients with left ventricular dysfunction
Chicos et al.
Am. J. Physiol. Heart Circ. Physiol. 2009;297:H743-H749.
ABSTRACT
| FULL TEXT
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
Hunt et al.
J Am Coll Cardiol 2009;53:e1-e90.
FULL TEXT
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
Jessup et al.
J Am Coll Cardiol 2009;53:1343-1382.
FULL TEXT
Quality Improvement: Science and Action
Ting et al.
Circulation 2009;119:1962-1974.
FULL TEXT
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA et al.
Circulation 2009;119:1977-2016.
FULL TEXT
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
2005 WRITING COMMITTEE MEMBERS et al.
Circulation 2009;119:e391-e479.
FULL TEXT
Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy
Shen et al.
Am. J. Physiol. Heart Circ. Physiol. 2009;296:H1089-H1095.
ABSTRACT
| FULL TEXT
Implantable Cardioverter-Defibrillators
Kukin et al.
NEJM 2009;360:937-938.
FULL TEXT
Improving Perioperative Temperature Management
Hannenberg and Sessler
Anesth. Analg. 2008;107:1454-1457.
FULL TEXT
Assessment of Autonomic Function in Cardiovascular Disease: Physiological Basis and Prognostic Implications
Lahiri et al.
J Am Coll Cardiol 2008;51:1725-1733.
ABSTRACT
| FULL TEXT
Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes
Gao et al.
Heart 2008;94:554-560.
ABSTRACT
| FULL TEXT
Use of {beta} blockers in patients with COPD
Au
Thorax 2008;63:296-298.
FULL TEXT
Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials
Cucherat
Eur Heart J 2007;28:3012-3019.
ABSTRACT
| FULL TEXT
Eulogy for a Quality Measure
Lee
NEJM 2007;357:1175-1177.
FULL TEXT
{beta}-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials
Sipahi et al.
ANN INTERN MED 2007;147:10-18.
ABSTRACT
| FULL TEXT
Predictors and Outcomes of Coronary Artery Bypass Grafting in ST Elevation Myocardial Infarction
Thielmann et al.
Ann. Thorac. Surg. 2007;84:17-24.
ABSTRACT
| FULL TEXT
Uncertainty on the Use of Aldosterone Antagonists for Primary Therapy for Sudden Cardiac Death in the Setting of Implanted Devices
Kloner and Cannom
Circulation 2007;115:2983-2989.
FULL TEXT
Acute Coronary Care in the Elderly, Part II: ST-Segment-Elevation Myocardial Infarction: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology
Alexander et al.
Circulation 2007;115:2570-2589.
ABSTRACT
| FULL TEXT
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden et al.
NEJM 2007;356:1503-1516.
ABSTRACT
| FULL TEXT
Outcomes Associated With the Use of Secondary Prevention Medications After Coronary Artery Bypass Graft Surgery
Goyal et al.
Ann. Thorac. Surg. 2007;83:993-1001.
ABSTRACT
| FULL TEXT
Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction
Rasmussen et al.
JAMA 2007;297:177-186.
ABSTRACT
| FULL TEXT
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions
Dzau et al.
Circulation 2006;114:2871-2891.
FULL TEXT
Beta-Blockers and Depression After Myocardial Infarction: A Multicenter Prospective Study
van Melle et al.
J Am Coll Cardiol 2006;48:2209-2214.
ABSTRACT
| FULL TEXT
Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic Population
Hays et al.
Stroke 2006;37:1715-1719.
ABSTRACT
| FULL TEXT
Clinical Trials in the Wake of Vioxx: Requiring Statistically Extreme Evidence of Benefit to Ensure the Safety of New Drugs
Roth-Cline
Circulation 2006;113:2253-2259.
FULL TEXT
{beta}2-Adrenergic Receptor Genetic Variants and Risk of Sudden Cardiac Death
Sotoodehnia et al.
Circulation 2006;113:1842-1848.
ABSTRACT
| FULL TEXT
Left insular stroke is associated with adverse cardiac outcome
Laowattana et al.
Neurology 2006;66:477-483.
ABSTRACT
| FULL TEXT
Statin and beta-blocker therapy and the initial presentation of coronary heart disease.
Go et al.
ANN INTERN MED 2006;144:229-238.
ABSTRACT
| FULL TEXT
Cost-Effectiveness of Hospital Pay-for-Performance Incentives
Nahra et al.
Med Care Res Rev 2006;63:49S-72S.
ABSTRACT
Additional Information
JAMA 2005;294:E1-E3.
FULL TEXT
Adherence to Medications by Patients After Acute Coronary Syndromes
Sud et al.
The Annals of Pharmacotherapy 2005;39:1792-1797.
ABSTRACT
| FULL TEXT
{beta}2-Adrenergic Receptor Genotype and Survival Among Patients Receiving {beta}-Blocker Therapy After an Acute Coronary Syndrome
Lanfear et al.
JAMA 2005;294:1526-1533.
ABSTRACT
| FULL TEXT
The Effectiveness of {beta}-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes
McDonald et al.
Diabetes Care 2005;28:2113-2117.
ABSTRACT
| FULL TEXT
Identifying and Assisting Low-Literacy Patients with Medication Use: A Survey of Community Pharmacies
Praska et al.
The Annals of Pharmacotherapy 2005;39:1441-1445.
ABSTRACT
| FULL TEXT
Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases
Jochmann et al.
Eur Heart J 2005;26:1585-1595.
ABSTRACT
| FULL TEXT
Three decades of clinical trials with beta-blockers: The contribution of the CAPRICORN trial and the effect of carvedilol on serious arrhythmias
Pratt
J Am Coll Cardiol 2005;45:531-532.
FULL TEXT
Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET
McBride and White
J Clin Pharmacol 2005;45:6-24.
ABSTRACT
| FULL TEXT
Acute {beta}-Blockade Increases Muscle Sympathetic Activity and Modifies Its Frequency Distribution
Cogliati et al.
Circulation 2004;110:2786-2791.
ABSTRACT
| FULL TEXT
Management of the Elderly Person After Myocardial Infarction
Aronow
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004;59:1173-1185.
ABSTRACT
| FULL TEXT
Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat
Barratt et al.
CMAJ 2004;171:353-358.
FULL TEXT
Social Support and Its Relationship to Morbidity and Mortality After Acute Myocardial Infarction: Systematic Overview
Mookadam and Arthur
Arch Intern Med 2004;164:1514-1518.
ABSTRACT
| FULL TEXT
Effect of {beta}-adrenergic blockade on dynamic electrical restitution in vivo
Hao et al.
Am. J. Physiol. Heart Circ. Physiol. 2004;287:H390-H394.
ABSTRACT
| FULL TEXT
Hypertensive Therapy: Part II
Franco et al.
Circulation 2004;109:3081-3088.
FULL TEXT
The cardiologist's toolbox: improving care
Ben-Yehuda
J Am Coll Cardiol 2004;43:2174-2176.
FULL TEXT
Implantable Defibrillators and Sudden Cardiac Death
Josephson and Wellens
Circulation 2004;109:2685-2691.
FULL TEXT
Prior convictions: bayesian approaches to the analysis and interpretation of clinical megatrials
Diamond and Kaul
J Am Coll Cardiol 2004;43:1929-1939.
ABSTRACT
| FULL TEXT
Primary Prevention of Sudden Cardiac Death: The Time of Your Life
Prystowsky
Circulation 2004;109:1073-1075.
FULL TEXT
Data feedback efforts in quality improvement: lessons learned from US hospitals
Bradley et al.
Qual Saf Health Care 2004;13:26-31.
ABSTRACT
| FULL TEXT
{beta}-Blocker Underuse in Secondary Prevention of Myocardial Infarction
Everly et al.
The Annals of Pharmacotherapy 2004;38:286-293.
ABSTRACT
| FULL TEXT
Secondary Prevention of Coronary Heart Disease in the Elderly
Dornbrook-Lavender et al.
The Annals of Pharmacotherapy 2003;37:1867-1876.
ABSTRACT
| FULL TEXT
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian et al.
Hypertension 2003;42:1206-1252.
ABSTRACT
| FULL TEXT
Sudden Cardiac Death
Antezano and Hong
J Intensive Care Med 2003;18:313-329.
ABSTRACT
Communitywide Trends in the Use and Outcomes Associated With {beta}-Blockers in Patients With Acute Myocardial Infarction: The Worcester Heart Attack Study
Silvet et al.
Arch Intern Med 2003;163:2175-2183.
ABSTRACT
| FULL TEXT
Drug Therapy for Prevention of Recurrent Myocardial Infarction
van der Elst et al.
The Annals of Pharmacotherapy 2003;37:1465-1477.
ABSTRACT
| FULL TEXT
Electrical Storm: Case Series and Review of Management
Srivatsa et al.
J CARDIOVASC PHARMACOL THER 2003;8:237-246.
ABSTRACT
Cost effectiveness of diagnostic strategies for patients with acute, undifferentiated chest pain
Goodacre and Calvert
Emerg. Med. J. 2003;20:429-433.
ABSTRACT
| FULL TEXT
Editorial: heart rate
Ferrari
Eur Heart J Suppl 2003;5:G1-G2.
Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era
Huikuri et al.
J Am Coll Cardiol 2003;42:652-658.
ABSTRACT
| FULL TEXT
National and State Trends in Quality of Care for Acute Myocardial Infarction Between 1994-1995 and 1998-1999: The Medicare Health Care Quality Improvement Program
Burwen et al.
Arch Intern Med 2003;163:1430-1439.
ABSTRACT
| FULL TEXT
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report
Chobanian et al.
JAMA 2003;289:2560-2571.
ABSTRACT
| FULL TEXT
The intersection between acute coronary syndrome and heart failure
Pfeffer
Eur Heart J Suppl 2003;5:C19-C23.
ABSTRACT
Review: Potential of renin inhibition in cardiovascular disease
Stanton
Journal of Renin-Angiotensin-Aldosterone System 2003;4:6-10.
ABSTRACT
MADIT-II and its implications
Moss
Eur Heart J 2003;24:16-18.
FULL TEXT
Impact of age and sex on sudden cardiovascular death following myocardial infarction
Abildstrom et al.
Heart 2002;88:573-578.
ABSTRACT
| FULL TEXT
Effect of {beta}-Blocking Therapy on Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT)
Ellison et al.
Circulation 2002;106:2694-2699.
ABSTRACT
| FULL TEXT
Effect of beta blockers after coronary artery bypass in postinfarct patients: what can we learn from available literature?
Geraci and Haan
Ann. Thorac. Surg. 2002;74:1727-1732.
ABSTRACT
| FULL TEXT
Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention
Chan et al.
J Am Coll Cardiol 2002;40:669-675.
ABSTRACT
| FULL TEXT
The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction: How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
Otterstad and Ford
Eur J Heart Fail 2002;4:501-506.
ABSTRACT
| FULL TEXT
{beta}-Blockers in the Post-Myocardial Infarction Patient
Gheorghiade and Goldstein
Circulation 2002;106:394-398.
FULL TEXT
{beta}-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction
Ko et al.
JAMA 2002;288:351-357.
ABSTRACT
| FULL TEXT
Sustained Ventricular Arrhythmias Among Patients With Acute Coronary Syndromes With No ST-Segment Elevation: Incidence, Predictors, and Outcomes
Al-Khatib et al.
Circulation 2002;106:309-312.
ABSTRACT
| FULL TEXT
Physicians' interpretation of "class effects": A need for thoughtful re-evaluation
Kennedy and Rosenson
J Am Coll Cardiol 2002;40:19-26.
ABSTRACT
| FULL TEXT
The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability
Silke et al.
J Psychopharmacol 2002;16:355-360.
ABSTRACT
Association Between Inhaled {beta}-Agonists and the Risk of Unstable Angina and Myocardial Infarction
Au et al.
Chest 2002;121:846-851.
ABSTRACT
| FULL TEXT
Morbidity and Mortality in Cardiovascular Disorders: Impact of Reduced Heart Rate
Singh
J CARDIOVASC PHARMACOL THER 2001;6:313-331.
Sudden Death Due to Cardiac Arrhythmias
Huikuri et al.
NEJM 2001;345:1473-1482.
FULL TEXT
Unrecognized Myocardial Infarction
Sheifer et al.
ANN INTERN MED 2001;135:801-811.
ABSTRACT
| FULL TEXT
Treatment of Perioperative Myocardial Ischemia
Zvara
SEMIN CARDIOTHORAC VASC ANESTH 2001;5:166-183.
ABSTRACT
Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management
The IONA Study Group
Heart 2001;85:9e-9.
ABSTRACT
| FULL TEXT
Reducing mortality from sudden cardiac death in the community: lessons from epidemiology and clinical applications research
Sotoodehnia et al.
Cardiovasc Res 2001;50:197-209.
ABSTRACT
| FULL TEXT
Clinical Trials of Antiarrhythmic Drugs in Postmyocardial Infarction and Congestive Heart Failure Patients
Camm and Yap
J CARDIOVASC PHARMACOL THER 2001;6:99-106.
Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy
Iwata et al.
J Am Coll Cardiol 2001;37:418-424.
ABSTRACT
| FULL TEXT
Health and Economic Benefits of Increased {beta}-Blocker Use Following Myocardial Infarction
Phillips et al.
JAMA 2000;284:2748-2754.
ABSTRACT
| FULL TEXT
Observational Studies and Randomized Trials
Kunz et al.
NEJM 2000;343:1194-1197.
FULL TEXT
Design and methodology of the CAPRICORN trial -- a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction
Dargie and The CAPRICORN Steering Committee
Eur J Heart Fail 2000;2:325-332.
FULL TEXT
Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials
Houghton et al.
Eur J Heart Fail 2000;2:333-340.
ABSTRACT
| FULL TEXT
Acute and Delayed Benefits of {beta}-Blockers During Coronary Intervention : True, True and Unrelated
Vetrovec
Circulation 2000;102:147-148.
FULL TEXT
Management of patients with myocardial infarction and hypertension
Lip et al.
Eur Heart J 2000;21:1125-1134.
A Comparison of Observational Studies and Randomized, Controlled Trials
Benson and Hartz
NEJM 2000;342:1878-1886.
ABSTRACT
| FULL TEXT
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
Concato et al.
NEJM 2000;342:1887-1892.
ABSTRACT
| FULL TEXT
Are {beta}-Blockers Effective in Elderly Patients Who Undergo Coronary Revascularization After Acute Myocardial Infarction?
Chen et al.
Arch Intern Med 2000;160:947-952.
ABSTRACT
| FULL TEXT
Catabolism in chronic heart failure
Berry and Clark
Eur Heart J 2000;21:521-532.
